英文名称 | HSD1590 |
---|
INCHI | InChI=1S/C20H18BN3O3/c1-27-20-13(6-3-7-15(20)21(25)26)19-12-5-2-4-11(12)18-14-10-22-24-16(14)8-9-17(18)23-19/h3,6-10,25-26H,2,4-5H2,1H3,(H,22,24) |
---|---|
InChi Key | WTZMCUOBQPTERK-UHFFFAOYSA-N |
Canonical SMILES | COc1c(cccc1B(O)O)c1nc2ccc3c(c2c2c1CCC2)cn[nH]3 |
PubChem CID | 139030519 |
PubChem CID | 139030519 |
---|
Ligand ID | 10424 |
---|---|
名称 | HSD1590 |
类别 | Synthetic organic |
学名 | 4-amino-N-(4,6-dimethylpyrimidin-2-yl)benzenesulfonamide |
生物活性评价 |
HSD1590 inhibits migration of MDA-MB-231 triple negative breast cancer cells in vitro, whereas netarsudil does not |
评价 |
HSD1590 is a boronic acid-containing Rho-associated kinase (ROCK) inhibitor |
1. Dayal N, Mikek CG, Hernandez D, Naclerio GA, Yin Chu EF, Carter-Cooper BA, Lapidus RG, Sintim HO. (2019) Potently inhibiting cancer cell migration with novel 3H-pyrazolo[4,3-f]quinoline boronic acid ROCK inhibitors.. Eur J Med Chem, 180 (13): (449-456). [PMID:31330446] |